Focusing on the R&D of multiple fine chemical products, we are deeply involved in the fields of CMIT/MIT bactericides and preservatives, Bromine derivatives, Laurocapram pharmaceutical excipients, and 1,1,2,2-Tetrachloroethane. With green synthesis processes as a breakthrough direction, we continuously optimize product purity and application performance, empowering diverse scenarios such as pharmaceuticals and daily chemicals, and steadily building a core barrier to R&D innovation.
We focus on tackling critical challenges in core chemical technologies, continuously increasing investment in R&D, and deeply cultivating process optimization and technological innovation to establish an autonomous and controllable core R&D system.
We deepen collaborative innovation across industry, academia, and research sectors; accelerate the commercialization and application of scientific achievements; and iteratively upgrade high-end products and green technologies to enhance our core technological competitiveness.
